PCSK9 Gene Summary [Human]

This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]

Details

Type
Nonsense Mediated Decay
Official Symbol
PCSK9
Official Name
proprotein convertase subtilisin/kexin type 9 [Source:HGNC Symbol;Acc:HGNC:20001]
Ensembl ID
ENSG00000169174
Bio databases IDs NCBI: 255738 Ensembl: ENSG00000169174
Aliases proprotein convertase subtilisin/kexin type 9
Synonyms FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, PC9, proprotein convertase subtilisin/kexin type 9
Species
Human, Homo sapiens
OrthologiesMouseRat

Protein Domains

A protein domain is a distinct structural or functional region within a protein that can evolve, function, and exist independently of the rest of the protein chain. These domains in human PCSK9 often fold into stable, three-dimensional structures and are associated with specific biological functions, such as binding to DNA, other proteins, or small molecules.
  • PCSK9 catalytic C-terminal domain
  • catalytic domain
  • Subtilase family
  • peptidase
  • receptor inhibitor
  • low-density lipoprotein receptor binding
  • low-density lipoprotein binding
  • protein binding
  • receptor binding
  • PCSK9_C-CRD
  • sodium channel inhibitor
  • Peptidase domain in the S8 and S53 families
  • serine endopeptidase
  • binding protein
  • Peptidase inhibitor I9
  • hinge domain
  • cysteine-histidine rich domain
  • Proprotein convertase subtilisin-like/kexin type 9 C-terminal domain
  • pro domain

Top Findings

The most significant associations for this gene, including commonly observed domains, pathway involvement, and functional highlights based on current data.
disease
  • non-insulin-dependent diabetes mellitus
  • cancer
  • neoplasia
  • homozygous familial hypercholesterolemia
  • sporadic hypercholesterolemia
  • hypercholesterolemia
  • abdominal aortic aneurysm
  • coronary artery disease
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
regulated by
regulates
role in cell
  • expression in
  • formation
  • accumulation in
  • quantity
  • proliferation
  • apoptosis
  • number
  • response
  • phosphorylation in
  • degradation in

Subcellular Expression

Locations within the cell where the protein is known or predicted to be active, providing insight into its function and cellular context.
  • Extracellular Space
  • Cytoplasm
  • cell surface
  • perinuclear region
  • Plasma Membrane
  • lysosome
  • Golgi Apparatus
  • Endoplasmic Reticulum
  • endoplasmic reticulum lumen
  • lysosome membrane
  • endosomal membrane
  • early endosomes
  • late endosomes
  • transport vesicles
  • plasma

Gene Ontology Annotations

Describes the biological processes, cellular components, and molecular functions associated with the human PCSK9 gene, providing context for its role in the cell.

Biological Process

Functions and activities the gene product is involved in
  • cholesterol metabolic process
  • triglyceride metabolic process
  • neurogenesis
  • lipoprotein metabolic process
  • phospholipid metabolic process
  • regulation of neuron apoptotic process
  • cholesterol homeostasis
  • positive regulation of neuron apoptotic process
  • cellular response to insulin stimulus
  • low-density lipoprotein particle receptor catabolic process
  • negative regulation of receptor recycling
  • kidney development
  • liver development
  • positive regulation of low-density lipoprotein particle receptor catabolic process
  • apoptotic process
  • negative regulation of sodium ion transmembrane transporter activity
  • negative regulation of receptor internalization
  • neuron differentiation
  • positive regulation of receptor internalization
  • lysosomal transport
  • cellular response to starvation
  • negative regulation of low-density lipoprotein particle clearance
  • protein autoprocessing
  • regulation of receptor activity

Cellular Component

Where in the cell the gene product is active
  • endolysosome membrane
  • late endosome
  • endoplasmic reticulum
  • Golgi apparatus
  • extracellular region
  • plasma membrane
  • lysosomal membrane
  • lysosome
  • cell surface
  • endoplasmic reticulum lumen
  • early endosome
  • extracellular space
  • perinuclear region of cytoplasm
  • cytoplasm
  • ER to Golgi transport vesicle
  • extrinsic to external side of plasma membrane

Molecular Function

What the gene product does at the molecular level
  • apolipoprotein binding
  • receptor inhibitor activity
  • RNA binding
  • low-density lipoprotein particle receptor binding
  • protein binding
  • very-low-density lipoprotein particle binding
  • serine-type endopeptidase activity
  • sodium channel inhibitor activity
  • low-density lipoprotein particle binding
  • very-low-density lipoprotein particle receptor binding
  • apolipoprotein receptor binding

Gene-Specific Assays for Results You Can Trust

Streamline your workflow with assays designed for this gene. Our targeted dPCR and qPCR assays help you generate meaningful data – efficiently and accurately.